Brief: Stayble Therapeutics Q2 EBIT Loss Widens To SEK 6.3 Million
17/08/2020 13:36
Aug 17 (Reuters) - Stayble Therapeutics AB STABL.ST :
* Q2 EBIT LOSS SEK 6.3 MILLION VERSUS LOSS SEK 1.2 MILLION YEAR AGO
Source text for Eikon: ID:nWkr46CrFL
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln